News
AZ claims another win for Imfinzi in frontline liver cancer
AstraZeneca has built the case for Imfinzi in earlier-stage liver cancer with a second phase 3 trial readout in its EMERALD programme.
News
DNA testing can help right racial imbalance in breast cancer
Study suggests routine genomic testing could correct well-established disparities in breast cancer survival rates between white and Black women.
News
Blackstone closes record $6.3bn life sciences fund
Blackstone has closed its latest fund – the $6.3bn BXLS VI – saying it is the largest ever private fund for the life sciences sector.
News
Amgen's BiTE for lung cancer backed for EU approval
Amgen's fast-growing bispecific T-cell engager Imdylltra should be cleared as a second-line therapy for small cell lung cancer, said the CHMP.
News
AI predicts liver cancer risk with "high accuracy"
A machine learning algorithm could serve as a pre-screen for hepatocellular carcinoma that identifies patients missed by current narrow guidance.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
